Physician profile
Mark Daniels
NPI 1346567757
$4,763.74
in general payments reported to CMS, 2019-2025
19 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2021: $546 · 2022: $1,366 · 2023: $735 · 2024: $673 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,219 · Consulting Fee: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,218.61 |
| Consulting Fee | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,803.77 | 2019-2022 | |
| Abbvie INC. | $1,478.74 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Stryker Corporation | $442.74 | 2022-2025 | |
| Integra Lifesciences Corporation | $201.92 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Kerecis Limited | $174.24 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Davol INC. | $150.88 | 2025 | |
| Pylant Medical | $81.05 | 2021-2024 | |
| Smith+Nephew, INC. | $75.66 | 2019-2023 | Renasys Go V2 Home |
| Sientra, INC. | $63.00 | 2022 | |
| Mimedx Group, INC. | $62.95 | 2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $51.16 | 2023-2024 | Clear+Brilliant |
| Mentor Worldwide LLC | $28.06 | 2019 | |
| Acera Surgical, INC. | $27.95 | 2025 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $25.39 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $23.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $21.90 | 2024 | Artiss |
| Merz North America, INC. | $19.58 | 2021 | |
| Galderma Laboratories, L.P. | $17.64 | 2022 | |
| Depuy Synthes Sales INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.